> In 2010, the French drug firm Sanofi Pasteur in Lyon ceased production of Fav-Afrique, an antibody serum that reduces the quantity of venom circulating in the

> In 2010, the French drug firm Sanofi Pasteur in Lyon ceased production of Fav-Afrique, an antibody serum that reduces the quantity of venom circulating in the blood of a snakebite victim. Here's the stated reason; http://www.usnews.com/news/business/articles/2015/09/07/doctors-without-borders-snakebite-treatment-running-out http://www.usnews.com/news/business/articles/2015/09/07/doct... : A spokesman for Sanofi Pasteur said the pharmaceuticals company was driven out of the market by competitors selling cheaper products, and it announced in 2010 it would stop making anti-venom. Those cheaper drugs are often seen as less effective. "It's very strange that the relevant stakeholders are only realizing this problem five years later," said Alain Bernal, a Sanofi Pasteur spokesman. He said the company has offered to transfer the anti-venom technology to others. ... WHO spokesman Gregory Hartl said the agency has a staffer working on the snakebite problem but donors have largely been uninterested. He said lack of snakebite treatment was also due to doctors deciding not to use anti-venoms because they were made from the wrong snake.